Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

QIAGEN Hopes to Double China Revenues in 2010

publication date: Aug 9, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
QIAGEN expects its China revenues to double this year, riding a wave of demand for its core sample and assay technologies. Last year, QIAGEN experienced a 90% increase in China sales, leading the company’s Asia Pacific region to a 40% gain, according to the head of the Asia Pacific division, Victor Shi. More details...

Stock Symbol: (NSDQ: QGEN)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...